Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.35% |
| 2 | Consumer Staples | 2.31% |
| 3 | Technology | 1.26% |
| 4 | Financials | 1.12% |
| 5 | Healthcare | 1.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SE
4901
DELISTED
Spectra Energy Corp Wi
SE
| $942K | ﹤0.01% |
+22,037
| New | +$839K |
|
4902
First Trust Water ETF
FIW
$1.89B
| $941K | ﹤0.01% |
24,907
-2,874
| -10% | -$106K |
|
4903
KraneShares CSI China Internet ETF
KWEB
$5.2B
| $941K | ﹤0.01% |
22,757
-3,329
| -13% | -$126K |
|
4904
CALL
8x8 Inc
EGHT
$287M
| $940K | ﹤0.01% |
60,900
+33,000
| +118% | +$469K |
|
|
LOGM
4905
CALL
DELISTED
LogMein, Inc.
LOGM
| $940K | ﹤0.01% |
10,400
+2,800
| +37% | +$224K |
|
|
ANFI
4906
PUT
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $940K | ﹤0.01% |
113,300
-82,600
| -42% | -$633K |
|
|
HK
4907
PUT
DELISTED
Halcon Resources Corporation
HK
| $940K | ﹤0.01% |
+100,200
| New | +$1.18M |
|
4908
CALL
Delek US
DK
$4.42B
| $939K | ﹤0.01% |
54,300
+9,000
| +20% | +$138K |
|
4909
Edison International
EIX
$27B
| $939K | ﹤0.01% |
13,000
| – | – |
|
4910
CALL
Gentex
GNTX
$4.78B
| $939K | ﹤0.01% |
+53,500
| New | +$924K |
|
4911
PUT
Brinker International
EAT
$9.87B
| $938K | ﹤0.01% |
18,600
-49,200
| -73% | -$2.47M |
|
4912
ProShares Ultra MSCI EAFE
EFO
$29.1M
| $938K | ﹤0.01% |
31,035
+11,379
| +58% | +$331K |
|
4913
PUT
Macerich
MAC
$6.73B
| $938K | ﹤0.01% |
11,600
+8,400
| +263% | +$710K |
|
4914
Direxion Daily FTSE China Bull 3X ETF
YINN
$670M
| $938K | ﹤0.01% |
2,456
-1,154
| -32% | -$404K |
|
4915
PUT
Steris
STE
$22.8B
| $936K | ﹤0.01% |
12,800
+900
| +8% | +$63.6K |
|
4916
PUT
Invesco Solar ETF
TAN
$1.26B
| $936K | ﹤0.01% |
46,100
-37,900
| -45% | -$800K |
|
4917
PUT
Rogers Corp
ROG
$2.24B
| $935K | ﹤0.01% |
15,300
+9,200
| +151% | +$558K |
|
4918
MaxLinear
MXL
$5.6B
| $933K | ﹤0.01% |
46,022
-43,628
| -49% | -$857K |
|
|
NUVA
4919
PUT
DELISTED
NuVasive, Inc.
NUVA
| $933K | ﹤0.01% |
14,000
+3,100
| +28% | +$197K |
|
4920
CALL
Cooper Companies
COO
$13.9B
| $932K | ﹤0.01% |
20,800
-46,400
| -69% | -$2.11M |
|
|
NGD
4921
CALL
DELISTED
New Gold Inc
NGD
| $932K | ﹤0.01% |
214,300
-38,700
| -15% | -$193K |
|
|
TVRD
4922
Tvardi Therapeutics
TVRD
$24.3M
| $932K | ﹤0.01% |
3,102
+2,486
| +404% | +$539K |
|
4923
CALL
Commerce Bancshares
CBSH
$8.32B
| $931K | ﹤0.01% |
30,786
+10,913
| +55% | +$326K |
|
|
ANSS
4924
DELISTED
Ansys
ANSS
| $930K | ﹤0.01% |
10,040
-5,516
| -35% | -$514K |
|
4925
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.96B
| $930K | ﹤0.01% |
+14,694
| New | +$931K |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q3 2016 filing shows 1,347 new, 3,278 increased, 3,435 reduced and 1,488 closed positions. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M. The largest sale was Apple, an estimated $762M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 93% a quarter earlier, followed by Consumer Staples and Technology.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.